Ajanta Pharma Q4FY21 consolidated PAT drops QoQ to Rs. 159.26 Cr

The companyreported total income of Rs.2915.67 crores during the 12 months period ended March 31, 2021

Gujarat Themis Biosyn Q4FY21 net profit lower at Rs. 5.79 Cr

Gujarat Themis Biosyn has reported total income of Rs.93.82 crores for FY 2020-21

Glenmark posts strong FY26 results with 27.5% revenue jump

Gandhar Oil posts robust FY26 profit

PAT soars 201%, EBITDA up 88% on strong PHPO demand & margin expansion

Fredun FY26 profit jumps 60% as revenue hits Rs. 639 Cr

SMS Pharma posts 48% profit surge in FY26 as margins expand & portfolio shift drives growth

Revenue from operations climbed 13% to Rs. 886.87 crore

Zota Health Care posts 83.86% revenue surge in FY26

Expands Davaindia network to 2,579 stores

Fortis Healthcare FY26 revenue crosses Rs. 9,100 crore

Q4 FY26 PAT jumps 44% to Rs. 271 crore, supported by acquisitions, specialty expansion, and diagnostics momentum

Sun Pharma reports FY26 revenue of Rs. 58,220 crore, net profit at Rs. 11,479 crore

Q4FY26 revenue rises 13.6% to Rs. 14,560 crore; quarterly net profit jumps 26.2% to Rs. 2,714 crore driven by India business and Innovative Medicines growth

Jubilant Pharmova posts 14% FY26 revenue growth to Rs. 8,280 crore amid margin pressure

Q4FY26 revenue climbs 19% to Rs. 2,290 crore as CDMO sterile injectables, radiopharma and generics businesses drive growth momentum